Literature DB >> 9635828

Temperature sensitivity of human wild-type and mutant p53 proteins expressed in vivo.

F Ponchel1, J Milner.   

Abstract

p53 is activated in response to DNA damage and functions in the maintenance of genetic integrity. Loss of p53 function because of mutation of the p53 gene is associated with over half all human cancers. Certain human p53 mutants are conformationally flexible in vitro and are temperature sensitive, with partial or complete recovery of wild-type (wt) properties at 32 degrees C. We have now tested the functional capacities of selected p53 mutants in vivo, by transfection into established human cell lines. Unexpectedly, we found that wt p53 can be temperature sensitive for transactivation of a co-transfected target gene in vivo. Flexible mutants retained varying degrees of functional capacity in transfected cells, and the recipient cell line appeared to be a significant determinant of both wt and mutant p53 function; importantly, two p53 null cell lines commonly used to study p53 function (Saos-2 and Hep3B) differed markedly in this latter respect. We also show that the p53 mutant V272M, which exhibits sequence-specific DNA binding in vitro, is nonetheless defective for transactivation and is unable to induce apoptosis in vivo. The valine 272 residue may thus be crucial for properties (other than sequence-specific DNA binding) that are important for p53 function(s) in vivo.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9635828      PMCID: PMC2150061          DOI: 10.1038/bjc.1998.256

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  30 in total

1.  Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53.

Authors:  D Michalovitz; O Halevy; M Oren
Journal:  Cell       Date:  1990-08-24       Impact factor: 41.582

2.  Redox modulation of p53 conformation and sequence-specific DNA binding in vitro.

Authors:  P Hainaut; J Milner
Journal:  Cancer Res       Date:  1993-10-01       Impact factor: 12.701

3.  Hepatocarcinoma-specific mutant p53-249ser induces mitotic activity but has no effect on transforming growth factor beta 1-mediated apoptosis.

Authors:  F Ponchel; A Puisieux; E Tabone; J P Michot; G Fröschl; A P Morel; T Frébourg; B Fontanière; F Oberhammer; M Ozturk
Journal:  Cancer Res       Date:  1994-04-15       Impact factor: 12.701

4.  Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line.

Authors:  D P Aden; A Fogel; S Plotkin; I Damjanov; B B Knowles
Journal:  Nature       Date:  1979-12-06       Impact factor: 49.962

5.  Temperature-dependent switching between "wild-type" and "mutant" forms of p53-Val135.

Authors:  J Milner; E A Medcalf
Journal:  J Mol Biol       Date:  1990-12-05       Impact factor: 5.469

6.  Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations.

Authors:  Y Cho; S Gorina; P D Jeffrey; N P Pavletich
Journal:  Science       Date:  1994-07-15       Impact factor: 47.728

7.  A functional screen for germ line p53 mutations based on transcriptional activation.

Authors:  T Frebourg; N Barbier; J Kassel; Y S Ng; P Romero; S H Friend
Journal:  Cancer Res       Date:  1992-12-15       Impact factor: 12.701

8.  Alteration of p53 damage response by tamoxifen treatment.

Authors:  C Guillot; N Falette; S Courtois; T Voeltzel; E Garcia; M Ozturk; A Puisieux
Journal:  Clin Cancer Res       Date:  1996-09       Impact factor: 12.531

9.  Temperature-sensitive mutants of p53 associated with human carcinoma of the lung.

Authors:  E A Medcalf; T Takahashi; I Chiba; J Minna; J Milner
Journal:  Oncogene       Date:  1992-01       Impact factor: 9.867

10.  Interaction of heat-shock protein 70 with p53 translated in vitro: evidence for interaction with dimeric p53 and for a role in the regulation of p53 conformation.

Authors:  P Hainaut; J Milner
Journal:  EMBO J       Date:  1992-10       Impact factor: 11.598

View more
  4 in total

1.  Self-aggregation and coaggregation of the p53 core fragment with its aggregation gatekeeper variant.

Authors:  Jiangtao Lei; Ruxi Qi; Guanghong Wei; Ruth Nussinov; Buyong Ma
Journal:  Phys Chem Chem Phys       Date:  2016-03-21       Impact factor: 3.676

Review 2.  Strategies for manipulating the p53 pathway in the treatment of human cancer.

Authors:  T R Hupp; D P Lane; K L Ball
Journal:  Biochem J       Date:  2000-11-15       Impact factor: 3.857

3.  Critical roles of p53 in epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma cells.

Authors:  Zheng Wang; Yuhui Jiang; Dongxian Guan; Jingjing Li; Hongkun Yin; Yi Pan; Dong Xie; Yan Chen
Journal:  PLoS One       Date:  2013-09-02       Impact factor: 3.240

4.  Temperature-sensitive ovarian carcinoma cell line (OvBH-1).

Authors:  Julia K Bar; Antonina Harlozinska; Sabine Kartarius; Mathias Montenarh; Ewa Wyrodek; Jan M Rodriguez Parkitna; Marian Kochman; Andrzej Ozyhar
Journal:  Jpn J Cancer Res       Date:  2002-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.